NEW YORK ─ Bio-Techne on Monday announced that Humana, a Medicare Advantage provider, has awarded a contract effective April 1 for coverage of its ExoDx Prostate (EPI) test for men performed at its Exosome Diagnostics laboratory.
Minneapolis, Minnesota-based Bio-Techne noted that Humana serves an estimated 20 million patients in the US.